Clinical Practice Guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology : 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease
© 2020 American Academy of Neurology..
This evidence-based clinical practice guideline for the prevention, diagnosis, and treatment of Lyme disease was developed by a multidisciplinary panel representing the Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR). The scope of this guideline includes prevention of Lyme disease, and the diagnosis and treatment of Lyme disease presenting as erythema migrans, Lyme disease complicated by neurologic, cardiac, and rheumatologic manifestations, Eurasian manifestations of Lyme disease, and Lyme disease complicated by coinfection with other tick-borne pathogens. This guideline does not include comprehensive recommendations for babesiosis and tick-borne rickettsial infections, which are published in separate guidelines. The target audience for this guideline includes primary care physicians and specialists caring for this condition such as infectious diseases specialists, emergency physicians, internists, pediatricians, family physicians, neurologists, rheumatologists, cardiologists and dermatologists in North America.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:96 |
|---|---|
| Enthalten in: |
Neurology - 96(2021), 6 vom: 09. Feb., Seite 262-273 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 23.02.2021 Date Revised 23.02.2021 published: Print-Electronic ErratumIn: Neurology. 2021 Feb 9;96(6):296. - PMID 33558404 Citation Status MEDLINE |
|---|
| doi: |
10.1212/WNL.0000000000011151 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM318238292 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM318238292 | ||
| 003 | DE-627 | ||
| 005 | 20231225164932.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1212/WNL.0000000000011151 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1060.xml |
| 035 | |a (DE-627)NLM318238292 | ||
| 035 | |a (NLM)33257476 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lantos, Paul M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical Practice Guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology |b 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.02.2021 | ||
| 500 | |a Date Revised 23.02.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumIn: Neurology. 2021 Feb 9;96(6):296. - PMID 33558404 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 American Academy of Neurology. | ||
| 520 | |a This evidence-based clinical practice guideline for the prevention, diagnosis, and treatment of Lyme disease was developed by a multidisciplinary panel representing the Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR). The scope of this guideline includes prevention of Lyme disease, and the diagnosis and treatment of Lyme disease presenting as erythema migrans, Lyme disease complicated by neurologic, cardiac, and rheumatologic manifestations, Eurasian manifestations of Lyme disease, and Lyme disease complicated by coinfection with other tick-borne pathogens. This guideline does not include comprehensive recommendations for babesiosis and tick-borne rickettsial infections, which are published in separate guidelines. The target audience for this guideline includes primary care physicians and specialists caring for this condition such as infectious diseases specialists, emergency physicians, internists, pediatricians, family physicians, neurologists, rheumatologists, cardiologists and dermatologists in North America | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 700 | 1 | |a Rumbaugh, Jeffrey |e verfasserin |4 aut | |
| 700 | 1 | |a Bockenstedt, Linda K |e verfasserin |4 aut | |
| 700 | 1 | |a Falck-Ytter, Yngve T |e verfasserin |4 aut | |
| 700 | 1 | |a Aguero-Rosenfeld, Maria E |e verfasserin |4 aut | |
| 700 | 1 | |a Auwaerter, Paul G |e verfasserin |4 aut | |
| 700 | 1 | |a Baldwin, Kelly |e verfasserin |4 aut | |
| 700 | 1 | |a Bannuru, Raveendhara R |e verfasserin |4 aut | |
| 700 | 1 | |a Belani, Kiran K |e verfasserin |4 aut | |
| 700 | 1 | |a Bowie, William R |e verfasserin |4 aut | |
| 700 | 1 | |a Branda, John A |e verfasserin |4 aut | |
| 700 | 1 | |a Clifford, David B |e verfasserin |4 aut | |
| 700 | 1 | |a DiMario, Francis J |c Jr |e verfasserin |4 aut | |
| 700 | 1 | |a Halperin, John J |e verfasserin |4 aut | |
| 700 | 1 | |a Krause, Peter J |e verfasserin |4 aut | |
| 700 | 1 | |a Lavergne, Valery |e verfasserin |4 aut | |
| 700 | 1 | |a Liang, Matthew H |e verfasserin |4 aut | |
| 700 | 1 | |a Meissner, H Cody |e verfasserin |4 aut | |
| 700 | 1 | |a Nigrovic, Lise E |e verfasserin |4 aut | |
| 700 | 1 | |a Nocton, James Jay J |e verfasserin |4 aut | |
| 700 | 1 | |a Osani, Mikala C |e verfasserin |4 aut | |
| 700 | 1 | |a Pruitt, Amy A |e verfasserin |4 aut | |
| 700 | 1 | |a Rips, Jane |e verfasserin |4 aut | |
| 700 | 1 | |a Rosenfeld, Lynda E |e verfasserin |4 aut | |
| 700 | 1 | |a Savoy, Margot L |e verfasserin |4 aut | |
| 700 | 1 | |a Sood, Sunil K |e verfasserin |4 aut | |
| 700 | 1 | |a Steere, Allen C |e verfasserin |4 aut | |
| 700 | 1 | |a Strle, Franc |e verfasserin |4 aut | |
| 700 | 1 | |a Sundel, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Tsao, Jean |e verfasserin |4 aut | |
| 700 | 1 | |a Vaysbrot, Elizaveta E |e verfasserin |4 aut | |
| 700 | 1 | |a Wormser, Gary P |e verfasserin |4 aut | |
| 700 | 1 | |a Zemel, Lawrence S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neurology |d 1951 |g 96(2021), 6 vom: 09. Feb., Seite 262-273 |w (DE-627)NLM000034355 |x 1526-632X |7 nnns |
| 773 | 1 | 8 | |g volume:96 |g year:2021 |g number:6 |g day:09 |g month:02 |g pages:262-273 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1212/WNL.0000000000011151 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 96 |j 2021 |e 6 |b 09 |c 02 |h 262-273 | ||